Opioid pseudopeptides containing heteroaromatic or heteroaliphatic nuclei

Peptides

Volumn 21, Issue 11, 2000, Pages 1663-1671

  Balboni, Gianfranco ^a   Salvadori, Severo ^b   Guerrini, Remo ^b   Bianchi, Clementina ^b   Santagada, Vincenzo ^c   Calliendo, Giuseppe ^c   Bryant, Sharon D ^d   Lazarus, Lawrence H ^d  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Agonism; Antagonism; Dmt; Dmt Tic pharmacophore; Opioid peptides; Peptide synthesis; Pharmacological bioassays; Receptor affinities

Indexed keywords

ALIPHATIC COMPOUND; AROMATIC COMPOUND; BENZIMIDAZOLE DERIVATIVE; CARBOLINE DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; DELTA OPIATE RECEPTOR; DELTORPHIN; DERMORPHIN; INDENE DERIVATIVE; ISOQUINOLINE DERIVATIVE; MU OPIATE RECEPTOR; OPIATE AGONIST; OPIATE PEPTIDE; PROPIONIC ACID DERIVATIVE; PSEUDOPEPTIDE;

ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG ANTAGONISM; DRUG CONFORMATION; DRUG RECEPTOR BINDING; PEPTIDE ANALYSIS; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION;

ALANINE; BENZIMIDAZOLES; BINDING SITES; CARBOLINES; CARBOXYLIC ACIDS; DIPEPTIDES; ISOQUINOLINES; KINETICS; LIGANDS; PEPTIDES; PROLINE; PROPIONIC ACIDS; PROTEIN CONFORMATION; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; SERINE; TETRAHYDROISOQUINOLINES; TYROSINE;

EID: 0033681556     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00315-6     Document Type: Article

References (46)

1. Antipsycoticactivity of substituted γ-carbolines
2. Opioid diketopiperazines: Synthesis and activity of a prototypic class of opioid antagonists
3. Opioid diketopiperazines: Refinement of the δ opioid antagonist pharmacophore
4. New δ opioid antagonists as pharmacological probes
5. Dmt (2',6'-dimethyl-L-tyrosine)-containing opioid peptides: Examination of C-terminal residues and spacer requirement for δ-, and μ- receptor properties
6. Design of μ selective opioid dipeptide antagonists
7. 4 amid bond isostere substitutions
8. Preparation and opioid activity of analogues of the analgesic dipeptide 2,6-dimethyl-L-tyrosyl-N-(3-phenylpropyl)-D-alaninamide
9. Design and solution structure of a partially rigid opioid antagonist lacking the basic center
10. A convenient asymmetric synthesis of the unnatural amino acid 2,6-dimethyl-L-tyrosine
11. Bioactive secretions of the amphibian integument. The integument, Series
12. Deltorphins: A family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites
13. 7-Spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands
14. Rational design of dynorphin A analogues with δ-receptor selectivity and antagonism for δ- and κ-receptors
15. 1]deltorphin B
16. 5]enkephalin
17. Synthesis of 2',6'-dimethyltyrosine containing tritiated δ opioid-receptor selective antagonist dipeptide ligands with extraordinary affinity
18. Agonists and antagonists bind to different domains of the cloned κ opioid receptor
19. Delta opioid receptor binding, selectivity and antagonism in vitro by Dmt-Tic compounds and a naltrindole analog
20. Frog skin opioid peptides: A case for environmental mimicry
21. Frontiers in protein chemistry and biotechnology
22. Design of δ-opioid peptide antagonists for emerging drug applications
23. What peptides these deltorphins be
24. Function of negative charge in the 'address domain' of deltorphins
25. Dermorphin gene sequence peptide with high affinity and selectivity for δ-opioid receptors
26. The dermorphin peptide family
27. Amino acid composition and sequence of dermorphin a novel opiate-like peptide from the skin of Phyllomedusa sauvagei
28. 6-dermorphin in skin extracts of the Brazilian frog Phyllomedusa rohdei
29. Synthesis of a novel class of heteroaromatic amino acids and their use in the preparation of analogues of luteinizing hormone-releasing hormone
30. 1 and opioid receptor agonists and antagonists
31. Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist
32. Role of spacer and address components in peptidomimetic δ opioid receptor antagonist related to naltrindole
33. δ Opioidmimetic antagonists: Prototypes for designing a new generation of ultraselective opioid peptides
34. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary δ opioid antagonist activity
35. 3-Substituted analogues of deltorphin C. Spatial conformation and topography of the aromatic ring in peptide recognition by δ opioid receptors
36. Further studies on the Dmt-Tic pharmacophore: Hydrophobic substituents at the C-terminus endows δ antagonists to manifest μ agonism or μ antagonism
37. Biological properties of opioid peptides replacing Tyr at position 1 by 2,6-dimethyl-Tyr
38. pA, a new scale for the measurement of drug action
39. 2[ψ] produces a potent analgesic effect,no physical dependence, and less tolerance than morphine in rats
40. TIPP opioid peptides: Development of extraordinarily potent and selective δ antagonists and observation of astonishing structure-intrinsic activity relationships
41. Differential stereochemical requirements of μ vs. δ opioid receptors for ligand binding, and signal transduction: Development of a class of potent and highly δ-selective peptide antagonists
42. Molecular mechanism of opioid selection
43. Conversion of enkephalin and dermorphin into δ-selective opioid antagonists by single-residue substitution
44. Selective opioid dipeptides
45. Design of a high affinity peptidomimetic opioid agonist from peptide pharmacophore models
46. A potent and selective endogenous agonist for the μ-opiate receptor